In contrast, only three pathways, namely olfactory transduction, hypertrophic cardiomyopathy, and pantothenate and CoA biosynthesis, were activated when POLD1 exhibited a high expression in NAFLD. The gene discussed is POLD1; the disease is hypertrophic cardiomyopathy.